ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 79 filers reported holding ROIVANT SCIENCES LTD in Q3 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,719,400 | -39.9% | 1,345,839 | -48.2% | 1.69% | -43.7% |
| Q2 2023 | $26,166,047 | -9.0% | 2,595,838 | -33.4% | 2.99% | -1.0% |
| Q1 2023 | $28,761,284 | -30.8% | 3,897,193 | -25.1% | 3.02% | -28.3% |
| Q4 2022 | $41,591,290 | +148.1% | 5,205,418 | 0.0% | 4.22% | +134.4% |
| Q3 2022 | $16,761,000 | -20.9% | 5,205,418 | 0.0% | 1.80% | -8.0% |
| Q2 2022 | $21,186,000 | -13.4% | 5,205,418 | +5.1% | 1.96% | -36.0% |
| Q1 2022 | $24,473,000 | -51.0% | 4,953,984 | 0.0% | 3.06% | -31.7% |
| Q4 2021 | $49,936,000 | – | 4,953,984 | – | 4.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $11,284,449 | 97.24% |
| QVT Financial LP | 122,541,536 | $1,235,218,683 | 67.65% |
| Patient Square Capital LP | 12,639,920 | $127,410,394 | 62.03% |
| Two Seas Capital LP | 7,909,591 | $79,728,677 | 17.43% |
| SB INVESTMENT ADVISERS (UK) LTD | 83,031,667 | $836,959,203 | 6.38% |
| Octagon Capital Advisors LP | 3,904,000 | $39,352,320 | 5.48% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $48,713,031 | 4.30% |
| VIKING GLOBAL INVESTORS LP | 75,238,700 | $758,406,096 | 3.10% |
| HSG Holding Ltd | 2,595,838 | $26,166,047 | 2.99% |
| Artia Global Partners LP | 824,363 | $8,309,579 | 2.86% |